‘Be Selective Buyers’ of Biotech, Raymond James Says

Raymond James is staying bullish on biotech. But analyst Christopher Raymond does urge some caution in a note published today launching coverage on a group of 10 stocks that include Biogen (BIIB), Celgene (CELG), and Amgen (AMGN). …we think the path of least resistance in biotech – even in light of last week’s broader market […]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.